The NHS Obesity Medication Pathway templates for Tirzepatide in both SystmOne and EMIS have been fully updated and aligned with the latest NICE and NHSE guidance. Clients will have access to consistent, clinically compliant templates that support the management of obesity with Tirzepatide, ensuring best practice and up-to-date recommendations for eligibility, initiation and titration are followed across both platforms.